Home Liver Diseases

Liver Diseases

Latest
Liver Diseases

Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum

Liver Diseases

FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis

Regulus Therapeutics has begun a restructuring that includes elimination of 60% of its workforce and a voluntary pause of its Phase I study for RGLS4326
Liver Diseases

Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program

Liver Diseases

$20 Blood Test Could Contribute to “Global HBV Elimination”

Liver Diseases

Pfizer Selects Final Two Targets in Hepatic Disease Partnership with Wave...

Liver Diseases

Alexion to Acquire Wilson Therapeutics for $855M

Liver Diseases

Regeneron, Alnylam to Pursue RNAi Treatments for NASH

Confocal image of the small intestine of animals colonized only with E. gallinarum. Compared
Liver Diseases

Leaky Gut Lets Bacteria Slip Away and Stir Up Autoimmunity

Fat content in fetal livers at the end of pregnancy from: (A) fetus of a normal weight mother during pregnancy and (B) fetus of an obese
Liver Diseases

Pregnancy Obesity Alters Fetal Liver Epigenetics and Metabolic Pathways

Liver Diseases

Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing

Load more

Recently Featured

Stay Connected

557,070FansLike
47,084FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up